|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.22 USD | 0.00% |
|
+45.70% | -17.01% |
| Jul. 15 | Anixa Biosciences Launches $5 Million Share Buyback Program; Shares Jump | MT |
| Jul. 15 | Anixa Biosciences, Inc. announces an Equity Buyback for $5 million worth of its shares. | CI |
Anixa Biosciences, Inc. reported earnings results for the full year ended October 31, 2021. For the full year, the company reported sales was USD 0.5125 million. Net loss was USD 12.95 million compared to USD 10.02 million a year ago.
Basic loss per share from continuing operations was USD 0.45 compared to USD 0.45 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.01% | 103M | |
| +25.83% | 46.56B | |
| +45.38% | 41.67B | |
| +0.69% | 41.16B | |
| +30.52% | 32.4B | |
| +22.30% | 28.18B | |
| -6.35% | 28.1B | |
| +49.25% | 14.52B | |
| +49.18% | 13.74B | |
| +3.45% | 12.17B |
ANIXA BIOSCIENCES, INC. 
